AN EXTRAORDINARY CASE: ARGUABLY, THE MOST DANGEROUS TUMOR EVER OPERATED IN BCMCH

 AN EXTRAORDINARY CASE: ARGUABLY, THE MOST DANGEROUS TUMOR EVER OPERATED IN BCMCH





We are thrilled to share a remarkable achievement in the field of surgical oncology at BCMCH. A patient with a massive retroperitoneal tumor underwent a complex and highly challenging surgery on May 28th and is being discharged today. This case stands out due to several extraordinary factors:

Key Features of the Case

  1. Huge Size

    • The tumor was notably large, making the surgical procedure exceptionally difficult.
  2. Critical Location

    • Positioned in a critical area, the retroperitoneal space, which houses vital structures, added to the complexity.
  3. Noradrenaline Secreting Tumor

    • The tumor was secreting noradrenaline, indicating it could be a pheochromocytoma or paraganglioma, which are rare and potentially life-threatening due to their impact on blood pressure and heart function.
  4. Multidisciplinary Involvement

    • The surgery required the collaboration of multiple specialities, reflecting the complexity and risk associated with the case.
  5. Extensive Preoperative Preparation

    • A rigorous two-month preparation phase was undertaken to ensure the patient's stability and readiness for surgery.

Medical and Surgical Team Involvement

The patient was initially evaluated by Dr. Jino Sebastian in Surgical Oncology. Given the tumor's characteristics, a multidisciplinary team (MDT) approach was essential. The team included:

  • Medical Endocrinology: Dr. Philip Finny and Dr. Anulekha
  • Surgical Endocrinology: Dr. Aneesh Sugunan
  • CTVS: Dr. Kannan
  • Cardiac Anaesthesia: Dr. Benson
  • Urology: Dr. Ninan Chacko
  • Nephrology: Dr. Geo
  • Pathology: Dr. Elizabeth
  • Radiology: Dr. Ashok

Extensive discussions were held with radiologists and pathologists to strategize the best approach for the surgery. The endocrinology team meticulously prepared the patient using alpha and beta blockers to manage the effects of the noradrenaline-secreting tumor.

The Surgical Procedure

After thorough preoperative preparations, including considerations for renal auto-transplantation, the surgery commenced with a well-prepared team and necessary equipment arranged by the diligent OT staff. The surgery, which lasted for 8 hours, was a success, culminating in the complete removal of the tumor.

Postoperative Outcome

The patient's postoperative course was smooth, and they are being discharged today, on postoperative day 5. This successful outcome is a testament to the expertise, coordination, and dedication of the entire medical team.

Conclusion

This extraordinary case highlights the exceptional skills and collaborative spirit at BCMCH. Special kudos to Dr. Jino Sebastian and the entire multidisciplinary team for their unwavering commitment and expertise in managing such a complex case. This achievement not only showcases the capabilities of our medical center but also underscores the importance of multidisciplinary collaboration in handling challenging medical cases.

We look forward to sharing more such success stories that reinforce our dedication to excellence in patient care and medical innovation.

Comments

Be Connected

NISD Sponsored REGIONAL SEMINAR ON AGING 2024

Diabetes Reversal: Myth or Reality? 🤔 Quest

BREATHE – Transforming Pulmonary Care

Proud Achievement: Our College Recognized as a Top 10 Promising Medical College

📚🌟 Spreading the Love for Reading: ATHENEUM Book Collection Campaign 🌟📚

Embracing Generosity: Bringing Joy to the Inmates of the Old Age Home

Bringing Hope and Healing: Celebrating the Expertise of our ENT Doctors at Medical College Hospital

Title: Breaking News: National Training Program on Pharmacovigilance to Enhance Drug Safety Introduction: In a significant development, the ADR Monitoring Centre of the Department of Pharmacology at BCMCH (Benedictine College of Medicine and Health Sciences) is conducting a National Training Program under the aegis of the Pharmaco Vigilance Program of India (PVPI). This program aims to educate and empower healthcare professionals to enhance drug safety through effective pharmacovigilance practices. With esteemed speakers and participants from across the country, this training program promises to be a transformative event for the field of pharmacology. Program Details: The National Training Program is scheduled for Friday, the 3rd of May, commencing at 7 PM. The program will feature distinguished speakers who are experts in the field of pharmacovigilance, including Dr. Shwetha Reba Mathews and Dr. Suman Varghese Sam. Dr. Mathews, who was recently appointed as one of the National Pharmacovigilance trainers, brings a wealth of experience and knowledge to the event. Dr. Sam, a renowned psychiatrist, will also be sharing valuable insights on drug safety from a mental health perspective. The program will be moderated by Dr. Jacob Jesurun, the Coordinator of the ADR Monitoring Centre. Importance of Pharmacovigilance: Pharmacovigilance plays a crucial role in ensuring the safety and well-being of patients. It involves the monitoring, detection, assessment, and prevention of adverse drug reactions (ADRs). By systematically collecting and analyzing data on drug safety, healthcare professionals can identify potential risks associated with medications and take appropriate measures to minimize harm. The National Training Program aims to foster a culture of pharmacovigilance across the country, ultimately leading to improved patient outcomes. Impact on Patient Safety: The primary objective of this training program is to equip healthcare professionals with the necessary skills and knowledge to identify and report adverse drug reactions effectively. By raising awareness about the importance of pharmacovigilance, the program seeks to enhance patient safety. Participants attending the program will gain a deeper understanding of the significance of adverse drug reaction monitoring and reporting, enabling them to contribute to a safer healthcare environment. National Reach: The National Training Program has attracted participants from all corners of the country. This diverse group of healthcare professionals represents various fields, including pharmacology, medicine, nursing, and pharmacy. The program's national scope reflects the growing recognition of the importance of pharmacovigilance in India and the commitment of healthcare professionals to ensuring the safe use of medications. Conclusion: As the National Training Program on Pharmacovigilance approaches, the Department of Pharmacology at BCMCH is poised to deliver an impactful and meaningful session. With esteemed speakers, expert moderation, and participants from across the country, this program promises to be a transformative event in the field of drug safety. By equipping healthcare professionals with the necessary knowledge and skills, the program aims to improve patient outcomes and contribute to a safer and more informed healthcare system. The efforts of the department and the participants in attending this training program are commendable, and their commitment to drug safety is an inspiration for the entire medical community.

BCMCH E-Cell Shines in IIT Bombay's Top 50!